
This study shows little evidence of harms or increased health care utilization for people receiving negative (normal) results of expanded carrier screening through genome sequencing.
This study shows little evidence of harms or increased health care utilization for people receiving negative (normal) results of expanded carrier screening through genome sequencing.
Among a Medicare population, use of 3 self-reported health items improves predicted inpatient admissions and healthcare costs when used with risk-prediction model.
Published: August 11th 2021 | Updated:
Published: December 20th 2011 | Updated:
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.